Advertisement

Virale Krankheiten im HNO-Bereich

  • E. Wilmes
  • F. Deinhardt
Conference paper
  • 18 Downloads
Part of the Verhandlungsbericht 1983 der Deutschen Gesellschaft für Hals- Nasen- Ohren-Heilkunde, Kopf- und Hals-Chirurgie book series (VBDG HNO, volume 1983 / 1)

Zusammenfassung

Virale Infektionen sind die Ursache einer Vielzahl von Erkrankungen im Bereich der Schleimhäute des oberen Respirations- und Digestionstraktes, der Speicheldrüsen und des Ohres.

Neue Erkenntnisse der letzten Jahre über die Pathogenese viraler Erkrankungen führen zum wachsenden Interesse des HNO-Facharztes an deren Diagnostik und Therapie.

Der allgemeine Teil dieses Referates macht mit wichtigen virologischen Grundlagen vertraut:

Es wird auf die Struktur und die Vermehrung der Viren eingegangen sowie eine Übersicht über die Pathogenese und die verschiedenen Formen viraler Infektionen gegeben.

Der Abschnitt Virus-Diagnostik beschreibt labordiagnostische Möglichkeiten und ihre Grenzen — und dient damit unter Verzicht auf labortechnische Details der Interpretation viraler Befunde.

Davon ausgehend werden Ansatzpunkte für Prophylaxe und Therapie viraler Erkrankungen diskutiert.

Der spezielle Teil des Referates faßt die für die HNO-Heilkunde wichtigen Virusinfektionen zusammen:

Hierzu gehören die viralen Infektionen der oberen Luft- und Speisewege, des Ohres und der Speicheldrüsen, sowie in gesonderter Darstellung die Herpesinfektionen.

Wegen seiner besonderen Bedeutung werden das Epstein-Barr Virus und seine assoziierten Erkrankungen sowie Thesen zur Genese EBV-korrelierter Tumoren ausführlich dargestellt.

Ein weiterer Abschnitt befaßt sich mit dem aktuellen Stand des Wissens über Interferon und seine bisher bekannte Wirkungsweise. Die Ergebnisse der interessantesten klinischen Studien werden diskutiert.

Ein letzter Abschnitt befaßt sich mit der Virushepatitis.

Summary

Viral infections cause many diseases in the mucous membranes, the upper respiratory and digestive tract, the salivary glands and the ear.

Recent advances in the pathogenesis of viral diseases brought about an increasing interest of otolaryngologists.

The general part of this paper presents the fundamental properties of viruses, their structure and replication, and the pathogenesis of the different forms of viral infections.

The section of viral diagnosis describes laboratory methods and their limits as well as the clinical interpretation of viral tests.

An overview of prophylaxis and therapy of viral infections is given.

The specialized section of the paper describes viral infections important for the otorhinolaryngologist. It includes infections of the aero-digestive tract, the ear and the salivary glands.

Because of its special importance, Epstein-Barr virus and its associated diseases, and hypotheses about the oncogenesis of EBV-correlated tumours are presented in detail.

The topic of the third part is the actual knowledge about interferon and its antiviral and antitumour effects. The findings of important clinical studies are discussed.

The last chapter concerns with virushepatitis.

Literaturverzeichnis

  1. Adam E (1982) Herpes simplex virus infections. In: Glaser R, Gotlieb-Stematsky (eds) Human herpes virus infections. Marcel Dekker, New York, pp 1–56Google Scholar
  2. Adams A (1979) The state of the virus genome in transformed cells and its relationship to host cell DNA. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 155–184CrossRefGoogle Scholar
  3. Allison AC (1974) On the role of mononuclear phagocytes in immunity against viruses. Frog Med Virol 18: 15–31Google Scholar
  4. Almeida JA, Tyrell DAJ (1967) The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. Virol 1: 175–178Google Scholar
  5. Anderson TW, Beaton GH, Corey PN (1975) Winter illness and vitamin C: The effect of relatively low doses. Can Med Assoc J 112: 823–826PubMedGoogle Scholar
  6. Anderson TW, Reid DBW, Beaton GH (1972) Vitamin C and the common cold: A double-blind trial. Can Med Assoc J 107: 503–508PubMedGoogle Scholar
  7. Anderson TW, Suranyi G, Beaton GH (1974) The effect of winter illness of large doses of vitamin C. Can Med Assoc J 111: 31–36PubMedGoogle Scholar
  8. Anderson-Anvret M, Forsby N, Klein G, Henle G (1977) Relationship between the EBV and undifferential nasopharyngeal carcinoma: Correlated nucleic acid hybridization and histopathological examination. Int J Cancer 20: 486–494CrossRefGoogle Scholar
  9. Aoki FY, Reed SE, Craig JW (1978) Effect of a polynucleotide interferon inducer of fungal origin on experimental rhinovirus infection in humans. J Infect Dis 137: 82–86PubMedCrossRefGoogle Scholar
  10. Arnold W, Ilberg C von (1971) Verbindungswege zwischen Liquor und Perilymphraum. Arch klin exp Ohr-, Nas-und Kehlk-Heilk 198: 247–261CrossRefGoogle Scholar
  11. Arnold W, Ilberg C von (1971) Die Verbindung zwischen Liquor cerebrospinalis und dem Lymphsystem der Mittelohrschleimhaut. Arch klirr exp Ohr-, Nas-u Kehlk-Heilk. 199: 453–457CrossRefGoogle Scholar
  12. Arnold W, Ilberg C von (1974) Ultrastrukturelle Veränderungen an der Mittelohrschleimhaut bei der idiopathischen haemorrhagisch-serösen Mittelohrentzündung (Otitis nigra). Arch Otorhinolaryngol 203: 15–32CrossRefGoogle Scholar
  13. Arnold W (1976) Ätiologische Aspekte zur Frage der Entstehung des Larynxpapilloms. Laryng Rhinol Otol 55: 102–111Google Scholar
  14. Arnold W (1979) Tubular forms of coronaviruses in human laryngeal papilloma. Arch Otolaryngol 225: 15–19Google Scholar
  15. Arnold W, Huth F (1979) Viren, virusähnliche und auf Viren hinweisende Strukturen beim Karzinom des Nasopharynx. Arch Otorhinolaryngol. (NY) 222: 295–312CrossRefGoogle Scholar
  16. Arnold W, Huth F (1979) Light and electron microscopic investigations of nasopharyngeal carcinomas with regard to the viral etiology of these tumors. J Cancer Res Oncol 94: 87–104CrossRefGoogle Scholar
  17. Arnold W, Huth F, Lindenberger J, Vosteen KH (1980) Vergleichende Morphologie des lymphoepithelialen Karzinoms; Primärtumor-Metastase-Xenotransplantat. Arch Otorhinolaryngol (NY) 226: 15–26CrossRefGoogle Scholar
  18. Arnold W, Vosteen KH (1980) Experimental studies on specific immunotherapy in nasopharyngeal carcinoma (NPC). Arch Otorhinolaryngol 229: 5–11PubMedCrossRefGoogle Scholar
  19. Arnold W, Nakazima A, Wang YB, Vosteen KH, Brunner H. Göbel U (1980) Aktuelle Aspekte zur Ätiologie, Diagnostik und Therapie des Nasenrachenraum-Karzinoms. HNO 28: 247–260PubMedGoogle Scholar
  20. Arnold W, Wang JB, Huth F, Klein M, Schmidt WAK (1981) Corona viruses and nasopharyngeal carcinoma. In: Grundmann E et al (eds) Nasopharyngeal carcinoma, Cancer campaign, Vol 5. G Fischer, Stuttgart New York, pp 441–448Google Scholar
  21. Arnold W, Klein W, Wang JB, Schmidt WAK, Trampisch HJ (1981) Corona virus associated antibodies in nasopharyngeal carcinoma. Arch Otorhinolaryngol 232: 165–177PubMedCrossRefGoogle Scholar
  22. Azimi PH, Cramblett HG, Haynes RE (1969) Mumps meningoencephalitis in children. JAMA 207: 509–512PubMedCrossRefGoogle Scholar
  23. Badger GF, Dingle JH, Feller AE (1953) A study of illness in a group of Cleveland families. II. Incidence of the common respiratory diseases. Am J Hyg 58: 31–40PubMedGoogle Scholar
  24. Bang HO, Bang J (1943) Involvement of the central nervous system in mumps. Acta Med Scand 113: 487–505CrossRefGoogle Scholar
  25. Baringer JR, Swoveland (1973) Recovery of herpes simplex virus from human trigeminal ganglions. N Engl J Med 288: 648–650PubMedCrossRefGoogle Scholar
  26. Baringer JR (1974) Recovery of herpes simplex virus from human sacral ganglion. N Engl J Med 291: 828–930PubMedCrossRefGoogle Scholar
  27. Barr B, Lundström R (1961) Deafness following maternal rubella. Acta Otolaryng 53: 413–423PubMedCrossRefGoogle Scholar
  28. Bastian FO, Rabson AS, Yee CL, Tralka TS (1972) Herpes virus horminis: Isolation from human trigerminal ganglions. Science 178: 306–307PubMedCrossRefGoogle Scholar
  29. Bayliss GJ, Wolf H (1980) Epstein-Barr virus-induced cell fusion. Nature 287: 164–165PubMedCrossRefGoogle Scholar
  30. Bayliss GJ, Wolf H (1981) An Epstein-Barr virus early protein induces cell fusion. Proc Natl Acad Sci USA 78: 7162–7165PubMedCrossRefGoogle Scholar
  31. Bayliss GJ, Wolf H (1981) The regulated expression of Epstein-Barr virus. III. Proteins specified by EBV during lytic cycle. J Gen Virol 56: 105–115PubMedCrossRefGoogle Scholar
  32. Beard CM, Benson RC, Kelalis PP (1977) The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974, Mayo Clinic. Proc Soc Acad Sci USA 52: 3–7Google Scholar
  33. Beal D, Naunton R (1966) Mumps hearing loss. A case report. Laryngoscope 76: 1780–1791CrossRefGoogle Scholar
  34. Becker A (1975) Die virusbedingten Erkrankungen im Hals- Nasen- Ohrenbereich. Arch klin exp Ohr-, Nas-u Kehlk-Heilk 167: 106–236CrossRefGoogle Scholar
  35. Becker W (1977) Das Nasopharynxkarzinom. Dtsch Ärzteblatt 74: 2319–2323Google Scholar
  36. Becker W, Herberhold C (1978) Klinik der Krankheiten des zervikalen Lymphknotensystems. In: Berendes, Link, Zöllner N (eds) Hals-Nasen-Ohren-Heilkunde in Praxis und Klinik, Bd III, G Thieme, Stuttgart, pp 14–14. 96Google Scholar
  37. Becker W, Naumann HH, Pfaltz CR (1982) Hals- Nasen- Ohrenheilkunde. G Thieme, Stuttgart New YorkGoogle Scholar
  38. Beckmann G (1962) Das hörgestörte Kind. Arch Ohr-, Nas-und Kehlk-Heilk 180: 1–202CrossRefGoogle Scholar
  39. Beg JA (1981) Bilateral sensorineural hearing loss as a complication of infectious mononucleosis. Arch Otolaryngol 107: 620–622PubMedCrossRefGoogle Scholar
  40. Bellanti JA (1971) Immunology. Saunders, PhiladelphiaGoogle Scholar
  41. Benjamin B, Ward SM (1932) Leucocytic response to measles. Am J Dis Child 44: 921–936Google Scholar
  42. Berger J (1981) Zur Epidemiologie prä-und perinataler Virusinfektionen. In: Spiess H (ed) Der prä-und perinatale Virusinfekt. Die Medizinische Verlagsgesellschaft mbH, Marburg/Lahn, pp 15–30Google Scholar
  43. Berkel AI, Henle W, Henle G, Klein G, Ersoy F, Sanal O (1979) Epstein-Barr virus-related antibody patterns in ataxia telangiectasia. Clin Exp Immunol 35: 196–201PubMedGoogle Scholar
  44. Bernstein TC, Wolff HG (1950) Involvement of the nervous system in infectious mononucleosis. Ann Intern Med 33: 1120–1138PubMedGoogle Scholar
  45. Bertaggia A, Meneghetti F, Cattetta M (1976) Observations on a case of parotis due to Coxsackie virus B3. G Mal Infect 28: 188–189Google Scholar
  46. Betuel H, Cammon M, Colombani J, Day N. Ellouz E (1975) The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisians. Int J Cancer 16: 249–254PubMedCrossRefGoogle Scholar
  47. Billiau A, Daume J von, Leuven F von, Edy VG, Ley M de, Cassiman JJ, Berghe H van den, Sourer P (1979) Human fibroblast interferon for clinical trials: Production, partial purification and characterization. Antimicrob Agents and Chemotherapy 16: 49–55Google Scholar
  48. Billiau A, Somer P de, Edy VG, Clerc QE de, Hereman H (1979) Human fibroblast interferon for clinical trials: Pharmokinetics and tolerability in experimental animals and humans. Antimicrob Agents and Chemotherapy 16: 56–63Google Scholar
  49. Birnbaum HC (1982) DNA strand breakage in human leukocytes exposed to a tumor promoter, phorbol acetate. Science 215: 1247CrossRefGoogle Scholar
  50. Black FL, Sheridan SR (1960) Studies on an attenuated measles-virus vaccine. IV. Administration of vaccine by several routes. N Engl J Med 263: 165–169PubMedCrossRefGoogle Scholar
  51. Black FL (1963) Discussion of paper by Karelitz S: Measles vaccine and immunity. NY J Med 63: 519–528Google Scholar
  52. Black FL (1963) A nationwide serum survey of United States military recruits. III. Measles and mumps antibodies. Am J Hyg 80: 304–307Google Scholar
  53. Black FL, Sheridan SR (1967) Blood leukocyte response to live measles vaccine. Am J Dis Child 113: 301–304PubMedGoogle Scholar
  54. Bleckley B, Friedmann I, Wright I (1967) Herpes zoster auris associated with facial nerve palsy and auditory nerve symptoms. Acta otolaryng 63: 533–550CrossRefGoogle Scholar
  55. Blacklock JWS (1957) Section of pathology with section of epidemiology and preventive medicine: Discussion on adenovirus infections. Proc Roy Soc Med 50: 753–755Google Scholar
  56. Blättner G, Maurer H (1966) Infektiöse Mononukleose und Tonsillen. HNO 14: 305–309PubMedGoogle Scholar
  57. Blank H, Eaglestein WH, Goldfaden (1970) Zoster a recrudescence of V-Z virus infection. Postgard med J. 46: 653–654CrossRefGoogle Scholar
  58. Blank H, Rake G (1955) Viral and rickettsial disease of the skin, eye and mucous membranes of man. Little Brown & Co, BostonGoogle Scholar
  59. Bloom HH (1962) Acute respiratory disease associated with Coxsackie A-21 virus infection. II. Incidence in military personnel: Observations in a non-recruit population. JAMA 179: 120–125PubMedCrossRefGoogle Scholar
  60. Bornkamm GW, Delius H, Zimber U, Hudewentz J, Epstein MA (1980) Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. J Virol 35: 603–618PubMedGoogle Scholar
  61. Bornkamm GW, Bühler G. Delius H (1981) Analysis of the genome of different Epstein-Barr virus strains. In: Grundmann et al (eds) Nasopharyngeal carcinoma, Cancer campaign, Vol 5. G Fischer, Stuttgart New York, pp 133–136Google Scholar
  62. Boyle WF, McCoy EG, Fogarty WA (1971) Electron microscopic identification of virus-like particles in laryngeal papilloma. Ann Otol Rhinol Laryngol 80: 693–699PubMedGoogle Scholar
  63. Boyle WF, Riggs JL, Oshiro LS, Lenette EH (1973) Electron microscopic identification of papova virus in laryngeal papilloma. Laryngoscope 83: 1102–1108PubMedCrossRefGoogle Scholar
  64. Bradburne AF, Bynde ML, Tyrrell DAJ (1967) Effects of a “new” human respiratory virus in volunteers. Br Med J 3: 767–769PubMedCrossRefGoogle Scholar
  65. Brandt CD, Kim HW, Arrobio JO (1973) Epidemiology of respiratory syncytial virus infection in Washington, DC III. Composite analysis of eleven consecutive yearly epidemics. Am J Epidemiol 98: 355–364PubMedGoogle Scholar
  66. Brichacek B, Suchanova A, Hirsch I, Sibl O, Rezavoca D. Zavadova H, Vonka V (1981) Presence of Epstein-Barr virus DNA in tonsillar tissues. Acta Virol 25: 361–370PubMedGoogle Scholar
  67. Brimblecombe FSW, Cruickshank R, Masters PL (1958) Family studies of respiratory infections. Br Med J 1: 119–128PubMedCrossRefGoogle Scholar
  68. Britten RJ, Kohne DE (1968) Repeated sequences in DNA. Science 161: 529–540PubMedCrossRefGoogle Scholar
  69. Britten RJ, Smith J (1970) A bovine genome. Carnegie Inst Yearbook 68: 378Google Scholar
  70. Brown JC (1970) Maternal virus infection and congenital anomalies. Arch Environ Health 21: 362–365PubMedGoogle Scholar
  71. Brunell PA, Brickmann A, O’Hare D (1968) Ineffectiveness of isolation of patients as a method of preventing the spread to mumps: Failure of the mumps skin-test to predict immune status. N Engl J Med 279: 1357–1361PubMedCrossRefGoogle Scholar
  72. Brunell PA (1981) Varicella-zoster infections. In: Feigin, Cherry (eds) Textbook of pediatrics infections diseases. Saunders, Philadelphia, pp 1206–1210Google Scholar
  73. Burgess RR (1969) A new method for the large scale purification of E. coli deoxyribonucleic acid-dependent ribonucleic acid polymerase. J Biol Chem 244: 6160–6167PubMedGoogle Scholar
  74. Behring Institute Mitteilungen 63 (1979) 137Google Scholar
  75. Burkitt D (1958) A sarcoma involving the jaws in African children. Brit J Surg 46: 218–223PubMedCrossRefGoogle Scholar
  76. Burkitt D (1962a) A children’s cancer dependent on climatic factors. Nature 194: 232–234PubMedCrossRefGoogle Scholar
  77. Burkitt D (1962b) Determining the climatic limitations of a children’s cancer common in Africa. Brit Med J II: 1019–1023CrossRefGoogle Scholar
  78. Burkitt DP (1969) Etiology of Burkitt’s lymphoma-an alternative hypothesis to a vectored virus. J Nat Cancer Inst 42: 19–28PubMedGoogle Scholar
  79. Butler WT, Waldmann TA, Rossen RD (1970) Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man. J Immunol 105: 584–591PubMedGoogle Scholar
  80. Calnek K, Hitchner SB (1969) Localization of viral antigen in chickens infected with Marek’s disease herpes virus. J Nat Cancer Inst 43: 935-PubMedGoogle Scholar
  81. Cantell K, Strander H (1977) Human leukocyte interferon for clinical use. In: Högmann CF, Lindhal-Kiessling K, Wigzell H (eds) Blood leukocytes: Function and use in therapy. Almquist & Wiksell Intern, Stockholm, pp 73–75Google Scholar
  82. Cantell K, Hirvonen S (1978) Large-scale production of human leukocyte interferon containing 10 units per ml. J Gen Virol 39: 541–543PubMedCrossRefGoogle Scholar
  83. Cate TR, Couch RB, Johnson KM (1964) Studies with rhinoviruses in volunteers: Production of illness, effect of naturally acquired antibody and demonstration of a protective effect onot associated with serum antibody. J Clin Invest 43: 56–67PubMedCrossRefGoogle Scholar
  84. Cate TR, Rossen RD, Douglas RG Jr (1966) The role of nasal secretion and serum antibody in the rhinovirus common cold. Am J Epidemiol 84: 352–363PubMedGoogle Scholar
  85. Cate TR, Douglas RG Jr, Couch RB (1969) Interferon and resistance to upper respiratory virus illness. Proc Soc Exp Biol Med 131: 631–636PubMedGoogle Scholar
  86. Chaddi A (1966) Med Afr Noire 13: 391–394Google Scholar
  87. Chang RS, Golden HD (1971) Transformation of human leukocytes by throat washings from infections mononucleosis patients. Nature 234: 359–360PubMedCrossRefGoogle Scholar
  88. Chanock RM, Bell JA, Parrott RH (1961) Natural history of parainfluenza infection. Perspect Virol 2: 126–139Google Scholar
  89. Chanock RM, Parrott RH (1965) Acute respiratory disease in infancy and childhood: Present understanding and prospects for prevention. Pediatrics 36: 21–39PubMedGoogle Scholar
  90. Chanock RM (1970) Control of acute mycoplasmal and viral respiratory tract disease. Science 169: 248–256PubMedCrossRefGoogle Scholar
  91. Chanock RM, Kapikian AZ, Mills J (1970) Influence of immunological factors in respiratory syncytial virus disease of the lower respiratory tract. Arch Environ Health 21: 347–355PubMedGoogle Scholar
  92. Chatterjee AK (1961) An unusual neurologic complication of infectious mononucleosis. Brit J Clin Pract 15: 595–598PubMedGoogle Scholar
  93. Cheatham WJ (1953) The relation of heretofore unreported lesions to pathogenesis of herpes zoster. Am J Path 29: 401–405PubMedGoogle Scholar
  94. Cheatham WJ, Weller T, Dolan TE, Dower JC (1956) Varicella: Report of two fatal cases with necroscopy, virus isolation and serologic studies. Am J Path 32: 1015–1019PubMedGoogle Scholar
  95. Cherry ID, Jahn CL (1965) Herpangina: The etiologic spectrum. Pediatrics 36: 632–634PubMedGoogle Scholar
  96. Chesney PJ, Dick EC (1981) Coronaviruses. In: Feigin RD, Cherry ID (eds) Textbook of pediatric infections diseases. WB Saunders, Philadelphia London Toronto, pp 1160–1166Google Scholar
  97. Chüden HG, Mickte W, Stehr K (1978) Hörstörungen bei endemischer Mumpserkrankung. Laryngol Rhinol 57: 745–750Google Scholar
  98. Clifford P (1970) On the epidemiology of nasopharyngeal carcinoma. Int J Cancer 5: 287–301PubMedCrossRefGoogle Scholar
  99. Connolly JH, Allen IV, Hurwitz LJ (1967) Measles-virus antibody and antigen in subacute sclerosing panencephalitis. Lancet 1: 542–544PubMedCrossRefGoogle Scholar
  100. Cooney MK, Hall CE, Fox JP (1972) The Seattle virus watch. III. Evaluation of isolation methods and summary of infections detected by virus isolations. Am J Epidemiol 96: 286–305PubMedGoogle Scholar
  101. Coovadia HM, Brain P, Hallett AF (1977) Immunoparesis and outcome in measles. Lancet 1: 619–621PubMedCrossRefGoogle Scholar
  102. Coovadia HM, Wesley A, Henderson LG (1978) Alterations in immune responsiveness in acute measles and chronic post-measles chest disease. Int Arch Allergy Appl Immunol 56: 14–23PubMedCrossRefGoogle Scholar
  103. Crawford DH, Epstein MA, Bornkamm GW, Achong BG, Finerty S, Thompson JL (1979) Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas. Int J Cancer 14: 294–302CrossRefGoogle Scholar
  104. Crawford DH, Rickinson AB, Finerty S, Epstein MA (1978) Epstein-Barr virus genome containing EB nuclear antigen-negative B-lymphocyte populations in blood in acute infectious mononucleosis. J Gen Virol 38: 449–460PubMedCrossRefGoogle Scholar
  105. Crouch NA, Rapp F (1972) Differential effect of temperature on the replication of herpes simplex virus type 1 and type 2. Virology 50: 939–941PubMedCrossRefGoogle Scholar
  106. Cudworth AG, White GBB, Woodrow JC (1977) Etiology of juvenile-onset diabetes. A prospective study. Lancet 1: 385–388PubMedCrossRefGoogle Scholar
  107. Dannenberg AM (1975) Macrophages in inflammation and infection. N Engl J Med 293: 489–493PubMedCrossRefGoogle Scholar
  108. Dascomb HE, Hilleman MR (1956) Clinical and laboratory studies in patients with respiratory disease caused by adenoviruses (RI-APC-ARD agents). Am J Med 21: 161–174PubMedCrossRefGoogle Scholar
  109. David JR (1973) Lymphocyte mediators and cellular hypersensitivity. N Engl J Med 288: 143–149PubMedCrossRefGoogle Scholar
  110. Deinhardt F (1973) Herpes virus saimiri. In: Kaplan AS (ed) The herpesviruses. Academic Press, New York London, pp 595–625Google Scholar
  111. Deinhardt F, Shramek GJ (1970) Mumps virus. In: Blair JE, Lennette EH, Truant JP (eds) Manual of clinical microbiology. Williams & Wilkins, Baltimore, pp 515–520Google Scholar
  112. Deinhardt F, Falk L, Wolfe LG, Paciga J, Johnson D (1975) Response of marmosets to experiments infection with Epstein-Barr virus. In: Thé G de, Epstein MA, zur Hausen H (eds) Oncogenesis and herpesviruses. IARC, Lyon, pp 161–168Google Scholar
  113. Deinhardt F, Deinhardt J (1979) Comparative aspects: Oncogenic animal herpes viruses. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 373–416CrossRefGoogle Scholar
  114. Denny-Brown D, Adamas RD, Fitzgerald PJ (1944) Pathologic features of herpes zoster. Arch Neurol Psychol 51: 216–231Google Scholar
  115. Desgranges C, Wolf H, Thé G de, Shanmugaratnam K, Camoun N. Ellouz R, Klein G, Lennert K, Munoz N, zur Hausen H (1975) Nasopharyngeal carcinoma: X. Presence of Epstein-Barr genomes in separated epithelial cells of tumors in patients from Singapore, Tunisia and Kenya. Int J Cancer 16: 7–15PubMedCrossRefGoogle Scholar
  116. Desgranges C, Li JY, Thé G de (1977) EBV specific secretory IgA in saliva of NPC patients. Presence of secretory piece in epithelial malignant cells. Engl Int J Cancer 20: 881–886CrossRefGoogle Scholar
  117. Devriese P (1968) Facial paralysis in cephalic herpes zoster. Ann Otol Rhinol Laryng 77: 1101–1119PubMedGoogle Scholar
  118. Devriese P (1974) Compression and ischemia of the facial nerve. Acta Otolaryng (Stockh) 77: 108–118CrossRefGoogle Scholar
  119. Diehl V, Schaadt M, Boie CH, Golinski C. Kirchner H, Günzel U, Glaser A (1981) Fibroblasten — Interferon. Vorläufige experimentelle und klinische Erfahrungen. Munch Med Wschr 123: 618–619Google Scholar
  120. Dingle JH, Badger GF, Feller AE (1953) A study of illness in a group of Cleveland families. I. Plan of study and certain general observations. Am J Hyg 58: 16–30PubMedGoogle Scholar
  121. Dippe SE, Bennet PH, Miller M (1975) Lack of causal association between Coxsackie B4 virus infection and diabetes. Lancet 1: 1314–1318PubMedCrossRefGoogle Scholar
  122. Dochez AR, Shibley GS, Mills KC (1930) Studies in the common cold. IV. Experimental transmission of the common cold to anthropoid apes and human beings by means of a filtrable agent. J Exp Med 52: 701–716PubMedCrossRefGoogle Scholar
  123. Döhnert G (1977) Über lymphoepitheliale Geschwülste, Erkenntnisse anhand der Gewebekultur und vergleichender klinischer, morphologischer und virologischer Untersuchungen. In: Sitzungsbericht der Heidelberger Akademie der Wissenschaften, 3. Abhandlung. Springer, Berlin Heidelberg New YorkGoogle Scholar
  124. Doerr W (1956) Über lymphoepitheliale Geschwülste Schmincke-Regaud. Ärztl Wschr 11: 169–173Google Scholar
  125. Doerr W (1961) Bösartige Geschwülste des Verdauungskanals. Kritische Bemerkungen zur Differentialdiagnose. Internist 2: 457–472Google Scholar
  126. Doerr W (1970) Spezielle pathologische Anatomie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  127. Dolgopol VB, Husson GS (1949) Infectious mononucleosis and neurological complications. Arch Intern Med 83: 179–184CrossRefGoogle Scholar
  128. Douglas RG Jr (1970) Pathogenesis of rhinovirus common colds in human volunteers. Ann Otol Rhinol Laryngol 79: 563–571PubMedGoogle Scholar
  129. Douglas RG Jr, Rossen RD, Butler WT (1967) Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum. J Immunol 99: 297–303PubMedGoogle Scholar
  130. Douglas RG Jr, Lindgren KM, Couch RB (1968) Exposure to cold environment and rhinovirus common cold. Failure to demonstrate effect. N Engl J Med 279: 742–747CrossRefGoogle Scholar
  131. Douglas RG Jr (1970) Pathogenesis of rhinovirus common colds in human volunteers. Ann Otol Rhinol Laryngol 79: 563–571PubMedGoogle Scholar
  132. Drettner B (1961) Vascular reactions of the human nasal mucosa on exposure to cold. Acta Otolaryng (Suppl) 166Google Scholar
  133. Dumas LB, Darby G, Sinsheimer RL (1971) The replication ofbacteriophage X 174 DNA in vitro. BBA 228: 407–412PubMedGoogle Scholar
  134. Egge K, Djupesland G, Modalsli B, Degre M (1981) Severe hearing loss and retinopathy in children: with rubella virus infection. Scand Audiol 10: 75–79PubMedCrossRefGoogle Scholar
  135. Einhorn S, Strander H (1977) Is interferon tissue specific? Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines. J Gen Virol 35: 573–577PubMedCrossRefGoogle Scholar
  136. Enberg RN, Eberle B, Williams RC (1974) T- and B-cells in peripheral blood during infectious mononucleosis. J Infect Dis 130: 104-PubMedCrossRefGoogle Scholar
  137. Enders JF, Bell JA, Dingle JH (1956) “Adenoviruses”: Groups name proposed for new respiratory tract viruses. Science 124: 119–120PubMedCrossRefGoogle Scholar
  138. Epstein MA, Achong BG, Barr YM (1964a) Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1: 702–703PubMedCrossRefGoogle Scholar
  139. Epstein MA, Barr YM (1964) Cultivation in vitro of human lymphoblasts from Burkitt’s malignant lymphoma. Lancet 1: 252–253PubMedCrossRefGoogle Scholar
  140. Epstein MA, Achong BG (1979) The relationship of the virus to Burkitt’s lymphoma. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp. 321–338CrossRefGoogle Scholar
  141. Esiri MM, Thompson AH (1972) Demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and election microscopy. J Neurol Sci 15: 35–48PubMedCrossRefGoogle Scholar
  142. Esslen E (1977) The acute facial palsies. Schriftenreihe Neurologie. Springer, Berlin Heidelberg New York, pp 29–34Google Scholar
  143. Eserly JR, Oppenheimer EH (1969) Pathological lesions due to congenital rubella. Arch Pathol 87: 380–388Google Scholar
  144. Fanta D, Söltz-Szöts J (1974) Interferon und Interferonstimulierung. Hautarzt 25: 313–318PubMedGoogle Scholar
  145. Fanta D (1976) Behandlung des Herpes simplex mit Tromantadinhydrochlorid. Wien Med Wschr 126: 315–317PubMedGoogle Scholar
  146. Fanta D, Mischer P (1976) Contact dermatitis from tromantadine hydrochloride. Contact Derm 2: 282–284PubMedCrossRefGoogle Scholar
  147. Fanta D, Tobaloglou A, Altmann H, Söltz-Szöts J (1976) Untersuchungen der DNA-Exzisionsreparatur in Lymphozyten von Patienten mit rezidivierendem Herpes simplex. ADF Tagung, BerlinGoogle Scholar
  148. Fenner F (1948) The pathogenesis of the acute exanthems. Lancet 2: 915–920PubMedCrossRefGoogle Scholar
  149. Fenner F (1976) Classification and nomenclature of viruses. Intervirology 7: 1–115PubMedCrossRefGoogle Scholar
  150. Fialkow PJ, Klein G, Gartler SM, Clifford P (1970) Clonal origin for individual Burkitt tumors. Lancet 1: 384–386PubMedCrossRefGoogle Scholar
  151. Fialkow PJ, Martin GM, Klein G, Clifford P, Singh H (1972) Evidence for a clonal origin of head and neck tumors. Int J Cancer 9: 133–142PubMedCrossRefGoogle Scholar
  152. Fisch U, Esslen E (1972) Total intratemporal exposure of the facial nerve. Arch Otolaryng 95: 335–341PubMedCrossRefGoogle Scholar
  153. Fisch U (1973) Operations on the facial nerve in its labyrinthine and meatal course. In: Miehlke A (eds) Surgery of the facial nerve. Urban & Schwarzenberg, München, pp 168–190Google Scholar
  154. Fisch U (1979) Fazialislähmungen im labyrinthären, meatalen und intrakraniellen Bereich. In: Berendes, Link, Zöllner (eds) Herpes zoster oticus, Klinik, Pathologie, Therapie. Hals- Nasen-Ohrenheilkunde in Praxis und Klinik 5: 21–21. 66Google Scholar
  155. Fisch U (1979) Current surgical treatment of intratemporal facial palsy. Clin in Plast Surg 6: 377–388Google Scholar
  156. Fisch U (1979) Surgery for Bell’s palsy and zoster oticus. Proc Symp Neurological Surgery of the Ear, SarasotaGoogle Scholar
  157. Fleischer G, Lennette ET, Henle G, Henle W (1979) Incidence of heterophil antibody response in children with infectious mononucleosis. J Ped 94: 723–726CrossRefGoogle Scholar
  158. Frenkel JK, Caldwell SA (1975) Specific immunity and nonspecific resistance to infection. J Infect Dis 131: 201–209PubMedCrossRefGoogle Scholar
  159. Frithiof L, Wersäll J (1967) Virus-like particles in human oral papilloma. Acta Otolaryngol 64: 263–266PubMedCrossRefGoogle Scholar
  160. Fox JP, Hall CE, Cooney MK (1972) The Seattle virus watch. II. Objectives, study population and its observation, data processing and summary of illness. Am J Epidemiol 96: 270–285PubMedGoogle Scholar
  161. Fox JP, Brandt CD, Wassermann FE (1969) The virus watch program: A continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: Virus excretion patterns, antibody response, efficiency of surveillance, patterns of infection, and relation of illness. Am J Epidemiol 89: 25–50PubMedGoogle Scholar
  162. Fox JP, Hall CE, Cooney MK (1977) The Seattle virus watch, VII. Observations of adenovirus infections. Am J Epidemiol 105: 362–386PubMedGoogle Scholar
  163. Foy HM, Grayson JT (1976) Adenoviruses. In: Evans AS (ed) Viral infections of humans: Epidemiology and control. Plenum Press, New York, pp 53–69CrossRefGoogle Scholar
  164. Fulginiti VA, Kempe CH (1970) The implications of specific infections susceptibilities in immune deficiency syndromes. In: Miescher P (ed) Immunpathology, Sixth international symposium. Grune & Stratton, New York, ppGoogle Scholar
  165. Gall JG, Pardue ML (1969) Formation and detection of RNA-DNA hybrid molecules in cytological preparations. Proc Natl Acad Sci USA 63: 378–383PubMedCrossRefGoogle Scholar
  166. Gall JG, Pardue ML (1972) Nucleic acid hybridization in cytological preparations. Meth Enyzmol XXI D: 470–480Google Scholar
  167. Gamble DR, Kinsley ML, Fitzgerald MG (1969) Viral antibodies in diabetes mellitus. Br Med J 3: 627–630PubMedCrossRefGoogle Scholar
  168. Gamble DR, Taylor KW (1969) Seasonal incidence of diabetes mellitus. Br Med J 3: 631–633PubMedCrossRefGoogle Scholar
  169. Gange RW, Bats AD, Bradstreet CM (1975) Cellular immunity and circulating antibody to herpes simplex in subjects with recurrent herpes simplex lesions and controls. Brit J Derm 97: 539–544CrossRefGoogle Scholar
  170. Gardner PS, Court SDM, Brocklebank JT (1973) Virus cross-infection in paediatric wards. Br Med J 2: 571–575PubMedCrossRefGoogle Scholar
  171. Gazzolo L, Thé G de, Viullaume M, Ho HC (1972) Nasopharyngeal carcinoma. II. Ultrastructure of normal mucosa, tumor biopsies and subsequent epithelial growth in vitro. J Nat Cancer Inst 48: 73–86PubMedGoogle Scholar
  172. Gelb LD, Kohne DE, Martin M (1971) Quantification of simian virus 40 sequences in African green monkey, mouse and virus-transformed cell-genomes. J Mol Biol 57: 129–131PubMedCrossRefGoogle Scholar
  173. Gerber P, Nonoyama M, Llucas S, Perlin E, Goldstein LI (1972) Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet 2: 988–989PubMedCrossRefGoogle Scholar
  174. Gergely L, Klein G, Ernsberg I (1971b) Effect of EBV-induced early antigens on host macromolecular synthesis studied by combined immunofluorescence and autoradiography. Virology 45: 22–29PubMedCrossRefGoogle Scholar
  175. Germer WD (1954) Viruserkrankungen des Menschen. G Thieme, StuttgartGoogle Scholar
  176. Ghatak NR, Zimmermann HM (1973) Spinal ganglion in herpes zoster. A light and electron microscopic study. Arch Path 59: 411–415Google Scholar
  177. Gissmann L (1977) Vergleichende Charakterisierung der Desoxyribonukleinsäuren menschlicher Papillomviren (HPV). Inaug Diss Univ Erlangen-NürnbergGoogle Scholar
  178. Glaser R, Lenoir G, Ho JHC, Thé G de (1975) In vitro production of EBV early antigens in NPC epithelial tumor cells by IUdR or superinfection. Biomedicine 23: 468–469PubMedGoogle Scholar
  179. Glaser R, Zimmermann J, Jeor SS, Rapp F (1975) Demonstration of a cellular inhibitor of Epstein-Barr and cytomegalievirus synthesis. Virology 64: 289–292PubMedCrossRefGoogle Scholar
  180. Glezen WP, Loda FA, Clyde WA Jr (1971) Epidemiologic patterns of acute lower respiratory disease of children in pediatric group practice. J Pediatr 78: 397–406PubMedCrossRefGoogle Scholar
  181. Glezen WP, Denny FW (1973) Epidemiology of acute lower respiratory disease in children. N Engl J Med 288: 498–505PubMedCrossRefGoogle Scholar
  182. Glezen WP (1977) Pathogenesis of bronchiolitis–epidemiologic considerations. Pediatr Res 11: 239–243PubMedGoogle Scholar
  183. Göbel U, Arnold W, Wehn V, Treuner J, Jürgens H, Cantell K (1981) Comparison of human fibroblast and leukocyte interferon in the treatment of severe laryngeal papillomatosis in children. Eur J Pediatr 137: 175–176PubMedGoogle Scholar
  184. Goepfert H, Guttermann JU, Dichtel WJ, Sessions RB, Gangir A, Sulek M (1982) Leukocyte interferon in patients with juvenile laryngeal papillomatosis. Ann Otol Rhinol Laryngol 91: 431–436PubMedGoogle Scholar
  185. Gold E, Carver DH, Heinberg J (1961) Viral infection. A possible cause of sudden, unexpected death in infants. N Engl J Med 264: 53–60PubMedCrossRefGoogle Scholar
  186. Golden HD, Chang RS, Prescott W, Simpson E, Cooper TY (1973) Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. J Infect Dis 127: 471–473PubMedCrossRefGoogle Scholar
  187. Good RA, Kelly WD, Rotstein J (1962) Immunological deficiency diseases. Hypogammaglobulinemia, Hodgkin’s disease and sarcoidosis. Progr Allergy 6: 187–319Google Scholar
  188. Goodpasture EW (1929) Herpetic infection with special reference to involvement of nervous system. Medicine (Baltimore) 8: 223–233CrossRefGoogle Scholar
  189. Gordon AG (1979) Mumps deafness. Brit Med J: 343–344Google Scholar
  190. Graessmann A, Wolf H, Bornkamm GW (1980) Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. Proc Natl Acad Sci USA 77: 433–436PubMedCrossRefGoogle Scholar
  191. Graffi A. Schramm T, Bender E, Graffi I, Horn KH, Bierwolf D (1968) Cell-free transmissible leukoses in Syrian hamsters, probably of viral etiology. Brit J Cancer 22: 577–581PubMedCrossRefGoogle Scholar
  192. Graffi A, Bender E, Schramm T, Kuhn W, Schneiders F (1969) Induction of transmissible lymphomas in Syrian hamsters by application of DNA from viral hamster papovavirus-induced tumors and by cell-free filtrates from human tumors. Proc Natl Acad Sci USA 64: 1172–1175PubMedCrossRefGoogle Scholar
  193. Graffi A, Bender E, Schramm T, Graffi I. Niezabitowski A, Schneiders F (1976) Durch ein Oncornavirus induzierte, zeltfrei übertragbare Sarkome des Goldhamsters. Arch Geschwulstforsch 46: 77–84PubMedGoogle Scholar
  194. Grayston JT, Peng IY, Lee GCY (1967) Congenital abnormalities following gestational rubella in Chinese. Report of a prospective study including five-year follow-up examinations after the 1957–1958 rubella epidemic in Taiwan (Formosa). JAMA 202: 1–6CrossRefGoogle Scholar
  195. Greenwood BM, Bradley-Moore AM, Palit A, Bryceson ADM (1972a) Immunosuppression in children with malaria. Lancet 1: 169–172PubMedCrossRefGoogle Scholar
  196. Greenberg SB, Harmon MW, Johnson PE, Couch R (1978) Antiviral activity of intranasally applied human leukocyte interferon. Antimicrobial Agents and Chemotherapy 14: 596–600PubMedGoogle Scholar
  197. Greenberg SB, Harmon MW, Johnson PE (1978) Activity of exogenous interferon in the human nasal mucosa. Tex Rep Biol Med 35: 491–496Google Scholar
  198. Gregg N McA (1941) Congenital cataract following German measles in the mother. Trans Ophthalinol Soc Aust 3: 35–46Google Scholar
  199. Grose C (1982) Varizella-zoster virus infection. In: Glaser R, Gotlieb-Stematsky (eds) Human herpes virus infections. Marcel Dekker, New York Basel pp 85–150Google Scholar
  200. Gross PA, Green RH, Cufnen MGM (1973) Persistent infection with parainfluenza type 3 virus in man. Am Rec Resp Dis 108: 894–898Google Scholar
  201. Günther O (1979) Zelluläre Immunität and Immunstatus. In: Die gelben Hefte 2: 49-Google Scholar
  202. Gumpel SM, Hayes K, Dugeon JA (1971) Congenital perceptive deafness: Role of intrauterine rubella. Br Med J 2: 300–308PubMedCrossRefGoogle Scholar
  203. Haglund S, Lundquist PG, Cantell K, Strander H (1981) Interferon therapy in juvenile laryngeal papillomatosis. Arch Otorhinolaryngol 107: 327–332Google Scholar
  204. Hall CB, Douglas KG (1976) Respiratory syncytial virus and influenza: practical community surveillance. Am J Dis Child 130: 615–620PubMedGoogle Scholar
  205. Hamilton JK, Paquin LA, Sullivan JL, Maurer HS, Cruzi FG, Provisor AJ, Steuber CP, Hawkins E, Yawn D, Cornet JA, Clausen K, Finkelstein GZ, Landing B, Grunnet M, Purtilo DT (1980) X-linked lymphoproliferative syndrome registry report. J Pediat 96: 669–671PubMedCrossRefGoogle Scholar
  206. Harbert F, Young I (1967) Audiologie findings in Ramsay Hunt syndrome. Arch Otolaryng 85: 632–639PubMedCrossRefGoogle Scholar
  207. Harmon MW, Greenberg SB, Johnson PE, Couch RB (1977) Human nasal epithelial cell culture system: evaluation of response to human interferons. Infect Immun 16: 480–485PubMedGoogle Scholar
  208. Hasegawa T (1971) Further electronmicroscopic observations of herpes zoster virus. Arch Derm 103: 45–48PubMedCrossRefGoogle Scholar
  209. Hayward GS, Frenkel N, Roizman B (1975) Anatomy of herpes simplex virus DNA: strain differences and heterogenicity in the locations of restriction endonuclease cleavage sites. Proc Nati Acad Sci USA 72: 1768–1772CrossRefGoogle Scholar
  210. Helms J (1982) Zur Therapie des Zoster oticus. Laryng Rhinol Otol 61: 380–382CrossRefGoogle Scholar
  211. Hemenway WG, Sando J, McChesney D (1969) Temporal bone pathology following maternal rubella. Arch Ohr-, Nas-and Kehlk-Heilk 193: 287–300CrossRefGoogle Scholar
  212. Henderson BE, Louie E, Bogdanoff E, Henle W, Alena B, Henle G (1974) Antibodies to herpes group viruses in patients with nasopharyngeal carcinoma and other head and neck cancers. Cancer Res 34: 1207–1210PubMedGoogle Scholar
  213. Hendley JO, Fishburne HB, Gwaltney JM, Jr (1972) Coronavirus infections in working adults, eight year study with 229E and OC43. Am Rev Resp Dis 105: 805–811PubMedGoogle Scholar
  214. Henle G, Henle W (1966) Immunofluorescense in cells derived from Burkitt’s lymphoma. J Bact 91: 1248–1256PubMedGoogle Scholar
  215. Henle G, Henle W, Diehl V (1968) Relation of Burkitt’s tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 59: 94–101PubMedCrossRefGoogle Scholar
  216. Henle W, Henle G, Ho HC, Burtin P, Cachin Y, Clifford P, Schryver A de, Thé G de, Diehl V, Klein G (1970) Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natn Cancer Inst 44: 225–231Google Scholar
  217. Henle W (1971) Evidence for a relation of the Epstein-Barr virus to Burkitt’s lymphoma and nasopharyngeal carcinoma. In: Nakahara W, Nishioka K, Hirayama T, Ito Y (eds) Recent advances in human tumor virology and immunology. University of Tokyo Press, Tokyo, pp 361–368Google Scholar
  218. Henle G, Henle W, Klein G (1971) Demonstration of two distinct components in the early antigen complex of EB-virus infected cells. Int J Cancer 8: 272–282PubMedCrossRefGoogle Scholar
  219. Henle W, Ho, HC, Henle G, Kwan HC (1973) Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active disease and long-term survivors. J Nat Cancer Inst 51: 361–373PubMedGoogle Scholar
  220. Henle W, Henle G (1973) Epstein-Barr virus and infectious mononucleosis. N Engl J Med 288: 263–264PubMedCrossRefGoogle Scholar
  221. Henle W, Henle G, Horwitz CA (1974) Epstein-Barr virus-specific diagnostic tests in infectious mononucleosis. Hum Pathol 5: 551–565PubMedCrossRefGoogle Scholar
  222. Henle G, Henle W (1976) Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17: 1–7PubMedCrossRefGoogle Scholar
  223. Henle W (1977) Faktorenanalyse der Tumorentstehung beim Menschen am Beispiel des Epstein-Barr Virus. Klin Wschr 55: 847–852PubMedCrossRefGoogle Scholar
  224. Henle W, Henle G (1978) The immunological approach to study of possibly virus-induced human malignancies using the Epstein-Barr virus as example. Prog Exp Tumor Res 21: 19–25PubMedGoogle Scholar
  225. Henle W, Henle G (1979) Seroepidemiology of the virus. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer Verlag, Berlin-Heidelberg-New York, pp 61–78CrossRefGoogle Scholar
  226. Herz G, Gfeller J (1977) Sinusitis in paediatrics. Chemotherapy 23: 50–57PubMedCrossRefGoogle Scholar
  227. Hierholzer JC, Farris WA (1974) Follow-up of children infected in a coxsackievirus B-3 and B-4 outbreak: No evidence of diabetes mellitus. J Infect Dis 129: 741–746PubMedCrossRefGoogle Scholar
  228. Hilding A (1930) The common cold. Arch Otolaryngol 12: 133–150CrossRefGoogle Scholar
  229. Hilfenhaus J (1981) Humaninterferon: Eigenschaften and Gewinnung. Immunobiol Informationen E v Behring 2: 41–49Google Scholar
  230. Hilleman MR (1957) Epidemiology of adenovirus respiratory infections in military population. Ann NY Acad Sci 67: 262–272PubMedCrossRefGoogle Scholar
  231. Hirayama T, Ito Y (1981) A new view of the etiology of nasopharyngeal carcinoma. Preventive Medicine 10Google Scholar
  232. Ho JHC (1971) Genetic and environmental factors in nasopharnygeal carcinoma. In: Nakahara W, Nishioka K, Hirayama T, Ito Y (eds) Recent advances in human tumor virology and immunology. University of Tokyo Press, Tokyo pp 275–282Google Scholar
  233. Ho HC (1972) Current knowledge of the epidemiology of nasopharyngeal carcinoma. A review. In: Biggs PM, Thé G de, Payne LN (eds) Oncogenesis and herpesviruses. IARC Scientific Publication No 2, Lyon, pp 357–366Google Scholar
  234. Ho JHC, Lau WH, Kwan HC, Chan CL, Au GKH, Saw D, Thé G de (1981) Diagnostic and prognostic serological markers in nasopharyngeal carcinoma (NPC). In: Grundmann (ed) Nasopharyngeal carcinoma. Cancer Campaign Vol 5. G. Fischer Verlag, Stuttgart-New York, pp 219–224Google Scholar
  235. Ho M (1962) Interferons. N Engl J Med 266: 1258, 1313 and 1367Google Scholar
  236. Hochstraßer K, Naumann R, Albrecht GJ (1983) Neue Methoden zur Erfassung des antiproteolytischen Systems im menschlichen Bronchialsecret, Atemwegs-und Lungenkrankheiten: in pressGoogle Scholar
  237. Hochstraßer K (1980) The acid stable proteinase inhibitors of the respiratory tract. Chemistry and function. Bull europ physiopath resp 16: 223–228Google Scholar
  238. Hodes D, Brunnell PA (1970) Mumps antibody: Placental transfer and disappearance during the first year of life. Paediatrics 45: 99–101Google Scholar
  239. Hope-Simpson RE (1965) The nature of herpes zoster: A long-term study and a new hypothesis. Proc R Soc Med 58: 9–20PubMedGoogle Scholar
  240. Horta-Barbosa L, Fuccillo DA, London WT (1969) Isolation of measles virus from brain cell cultures of two patients with subacute sclerosing panencephalitis. Proc Soc Exp Biol Med 132: 272–277PubMedGoogle Scholar
  241. Horta-Barbosa L, Fuccillo DA, Sever JL (1969) Subacute sclerosing panencephalitis: Isolation of measles virus from a brain biopsy. Nature 221: 974–976PubMedCrossRefGoogle Scholar
  242. Horta-Barbosa L, Krebs H, Ley A (1971) Progressive increase in cerebrospinal fluid measles antibody levels in subacute sclerosing panencephalitis. Pediatrics 47: 782–783PubMedGoogle Scholar
  243. Howlett JG, Somlo F, Kalz F (1957) A new syndrome of parotitis with herpangina caused by the coxsackie virus. Can Med Assoc 77: 5–7Google Scholar
  244. Huang DP, Ho JHC, Henle W, Henle G (1974) Demonstration of EBV-associated nuclear antigens in NPC cells from fresh biopsies. Int J Cancer 14: 580–588PubMedCrossRefGoogle Scholar
  245. Huang DP, Ho JHC, Henle W, Henle G, Saw D, Lui M (1978) Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to EBV-serology. Int J Cancer 22: 266–274PubMedCrossRefGoogle Scholar
  246. Huebner RJ, Cole RM, Beeman EA (1951) Herpangina: Etiological studies of a specific infectious disease. JAMA 145: 628–633CrossRefGoogle Scholar
  247. Huizing EH (1980) Herpes zoster oticus. In: Berendes J, Link R, Zöllner F (eds) HNO-Heilkunde in Praxis und Klinik, Bd 6. G Thieme Verlag, Stuttgart-New York, pp 45.23–45.31Google Scholar
  248. Hyd’en D, Odkvist LM, Kyl’en P (1979) Vestibular symptoms in mumps deafness. Acta Otolaryngol (Suppl) 360: 182–183Google Scholar
  249. Interferone nomenclature (1980) Nature 286: 110CrossRefGoogle Scholar
  250. Isaacs A, Lindemann J (1957) Virus interference. I. The interferon. Proc Royal Soc B 147: 258–267CrossRefGoogle Scholar
  251. Ishikawa K (1936) Klinische und experimentelle Untersuchungen über die Entstehungsursachen der Papillome Fukuoka Acta Med 29: 87–88Google Scholar
  252. Ito Y, Kishishita M, Morigaki T, Yanase S, Hirayama T (1981) Induction and intervention of Epstein-Barr virus expression in human lymphoblastoid cell lines: A simulation model for study of cause and prevention of nasopharyngeal carcinoma and Burkitt’s lymphoma. In: Grundmann et al (eds) Nasopharyngeal carcinoma, Cancer Campaign Vol 5, G Fischer Verlag, Stuttgart-New York, pp 225–262Google Scholar
  253. Jackson GG (1964) Understanding of viral respiratory illness provided by experiments in volunteers. Bacteriol Rev 28: 423–430PubMedGoogle Scholar
  254. Jaffe BF, Maassab HF (1967) Sudden deafness associated with adenovirus infection. N Engl J Med 276: 1406–1408PubMedCrossRefGoogle Scholar
  255. Jahnke V (1974) Elektronenmikroskopische Befunde am normalen menschlichen Nasenrachenepithel. Laryngol Rhinol Otol 53: 290–300Google Scholar
  256. Jensema C (1974) Post-rubella children in special educational programs for the hearing impaired. Volta Review 76: 466–473Google Scholar
  257. Jensen J (1969) Malformation of the inner ear in deaf children. Acta Radiol (Suppl) 286Google Scholar
  258. Johnson HM, Baron S (1976) Regulatory role of interferons in the immune response. IRCS J Med Sci 4: 50Google Scholar
  259. Johnson HM, Baron S (1977) Evaluation of effects of interferon and interferon inducers on the immune response. Pharmacol Therap 1: 349–352Google Scholar
  260. Johnson HM, Baron S (1976a) Interferon as the mediator of the suppressive effects of some interferon inducers in the in vitro immune response. IRCS J Med Sci 4: 312–316Google Scholar
  261. Johnson KM (1962) Acute respiratory disease associated with coxsackie A-21 virus infection. I. Incidence in military personnel: Observations in a recruit population. JAMA 179: 112–119PubMedCrossRefGoogle Scholar
  262. Johnson KM, Bloom HH, Forsyth B (1962) Relative role of identifiable agents in respiratory disease. II. The role of enteroviruses in respiratory disease. Am Rev Resp Dis 88: 240–245Google Scholar
  263. Kapikian AZ, Bell JA, Mastrota FM (1961) An outbreak of febrile illness and pneumonia associated with respiratory syncytial virus infection. Am J Hyg 74: 234–248PubMedGoogle Scholar
  264. Kapikian AZ (1975) The coronaviruses. Dev Biol Stand 28: 42–64PubMedGoogle Scholar
  265. Karlowski TR, Chalmers TC, Frenkel LD (1975) Ascorbic acid for the common cold–a prophylactic and therapeutic trial. JAMA 231: 1038–1042PubMedCrossRefGoogle Scholar
  266. Kelemen G (1966) Rubella and deafness. Arch Otolaryng 83: 520–532PubMedCrossRefGoogle Scholar
  267. Kim HW, Arrobio JO, Brandt CD (1973) Epidemiology of respiratory syncytial virus infection in Washington, DC. I. Importance of the virus in different respiratory disease syndromes and temporal distribution of infection. Am J Epidemiol 98: 216–225PubMedGoogle Scholar
  268. Klein G, Giovanella BC, Lindhal T, Fialko PJ, Singh S, Stehlin JS (1974) Direct evidence for the presence.of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci USA 71: 4737–4741PubMedCrossRefGoogle Scholar
  269. Klein G (1975) The Epstein-Barr virus and neoplasia. N Engl J Med 293: 1353–1357PubMedCrossRefGoogle Scholar
  270. Klein G (1979) Lymphoma development in mice and humans. Diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci USA 76: 2442–2446PubMedCrossRefGoogle Scholar
  271. Klein G (1980) Viral oncology. Raven Press, New YorkGoogle Scholar
  272. Klein JO, Teele DW (1976) Isolation of viruses and mycoplasmas from middle ear effusions. A review. Am Otol (Suppl) 25: 140–144Google Scholar
  273. Kleinschmidt S (1975) Mumpsschutzimpfung und Viruslebendimpfungen. Deutsches Grünes Kreuz 159–162Google Scholar
  274. Kraus NS (1960) La parotite da virus Coxsackie. Estratto Minerva Medica 51: 1379–1381Google Scholar
  275. Krech U (1981) Diagnostik und Prävention prä-und perinataler Virusinfektionen: Zytomegalie und andere Herpesviren. In: Spiess H (ed) Der prae-und perinatale Virusinfekt. Die Medizinische Verlagsgesellschaft mbH, Marburg/Lahn, pp 95–106Google Scholar
  276. Kress S, Schluederberg AE, Hornick RB (1961) Studies with live attenuated measles-virus vaccine. II. Clinical and immunologic response of children in an open community. Am J Dis Child 101: 701–707PubMedGoogle Scholar
  277. Kressner A (1980) Tympanogene Labyrinthitis. In: Berendes J. Link R, Zöllner N (eds) HNO-Heilkunde in Praxis und Klinik, Ohr II. G Thieme, Stuttgart New York, pp 29.1–29.35Google Scholar
  278. Krüger J, Ierohnimon V, Dahr W (1981) Frequencies of HLA antigens in patients with NPC. In: Grundmann (eds) Nasopharyngeal Carcinoma, Cancer Campaign Vol 5. G. Fischer, Stuttgart New York, pp 201–204Google Scholar
  279. Kruse W (1914) Die Erreger von Husten und Schnupfen. Munch Med Wschr 61: 1547–1552Google Scholar
  280. Lanier AP, Henle W, Bender ThR, Talbot ML (1980) Epstein-Barr virus-specific antibody titers in seven Alaskan natives before and after diagnosis of nasopharyngeal carcinoma. Int J Cancer 26: 133–138PubMedCrossRefGoogle Scholar
  281. Lanier AP, Talbot M, Clift S, Tschopp C, Dohan P, Bornkamm G, Henle W (1978) Epstein-Barr virus DNA in tumor tissue from native Alaskan patients with nasopharyngeal carcinoma. Lancet II: 1095–1098CrossRefGoogle Scholar
  282. Lee GC-Y, Funk GA, Chen ST, (1973) An outbreak of respiratory syncytial virus infection in an infant nursery. J Formosan Med Assoc 72: 39–46Google Scholar
  283. Lee SHS, O’Shanghnessy HV, Rowe KR (1972) Interferon induced growth in diploid and heteroploid human cells. Proc Soc Exptl Biol Med 139: 1438–1440Google Scholar
  284. Lefkowitz LJ, Jr, Jackson GG (1966) Dual respiratory infection with parainfluenza and rhinovirus: The pathogenesis of transmitted infection in volunteers. Am Rev Resp Dis 93: 519–528PubMedGoogle Scholar
  285. Lehner T, Wilton JM, Shillitoe EJ (1975) Immunological basis for latency recurrences and putative oncogenicity of herpes simplex virus. Lancet 2: 60–62PubMedCrossRefGoogle Scholar
  286. Leicher H (1952) Taubstummheit, Vestibularschaden und Mißbildungen des äußeren Ohres als Symptome der Röteln-Embryopathie. Z Laryng Rhinol 31: 128–138Google Scholar
  287. Leidel J, Eggers HJ (1978) Die Gruppen der Viren. In: Otte HJ, Brandis H (eds) Lehrbuch der medizinischen Mikrobiologie. G Fischer, Stuttgart New York, pp 447–536Google Scholar
  288. Lenoir G, Thé G de (1978) Epstein-Barr virus–epithelial cell interaction and its implication in the etiology of nasopharyngeal carcinoma. In: Thé G de, Ito Y (eds) Nasopharyngeal carcinoma: etiology and control. IARC, Lyon, pp 377–384Google Scholar
  289. Lightwood R, Nolan R, Franco M (1970) Epithelial giant cells in measles as an aid in diagnosis. J Pediatr 77: 59–64PubMedCrossRefGoogle Scholar
  290. Lin TM, Yang CS, Ho SW, Chiou JF, Liu CH, Tu SM, Chen KP, Ito YH, Kawamura A, Hirayama T (1972) Antibodies to herpes-type virus in nasopharyngeal carcinoma and control groups. Cancer 29: 603–609PubMedCrossRefGoogle Scholar
  291. Lindahl T, Klein G, Reedman BM, Johannson B, Singh S (1974) Relationship between EBV-DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. Int J Cancer 13: 764–772PubMedCrossRefGoogle Scholar
  292. Muir CS (1971) Nasopharyngeal carcinoma in non Chinese populations with special reference to South-East Asia and Africa. Int J Cancer 8: 351–363PubMedGoogle Scholar
  293. Muir CS, Shanmugaratnam K (eds) (1967) Cancer of the Nasopharynx. Munksgaard, Copenhagen Mündnich K, Terrane K (1979) Mißbildungen des Ohres. In: HNO-Heilkunde in Praxis und Klinik. Bd 5, Ohr I, G Thieme, Stuttgart, pp 18–18. 49Google Scholar
  294. Nadol JB (1977) Viral particles in nasopharyngeal carcinoma. Laryngoscope 87 /2: 1932–1937PubMedGoogle Scholar
  295. Nager F von (1907) Beiträge zur Histologie der erworbenen Taubstummheit. Z Ohrenheilk 54: 217-ffGoogle Scholar
  296. Nager F von (1952) Histologische Ohruntersuchungen bei Kindern nach mütterlicher Rubella. Pract Oto-Rhino-Laryng 14: 337–359Google Scholar
  297. Nahmias AJ, Naib ZM, Josey WE, Franklin E, Jenkins R (1973) Prospective studies of the association of genital herpes simplex viruses 1 and 2. N Engl J Med 289: 667–674PubMedCrossRefGoogle Scholar
  298. Nasemann T (1974) Viruskrankheiten der Haut, der Schleimhäute und des Genitales. G Thieme, StuttgartGoogle Scholar
  299. Naumann HH (1980) On the defense mechanisms of the repiratory mucosa towards infection. Acta Otolaryngol 89: 165–176PubMedCrossRefGoogle Scholar
  300. Naumann HH (1978) Die Abwehrprinzipien der respiratorischen Schleimhaut gegenüber Infektionen. HNO 26: 397–405PubMedGoogle Scholar
  301. Neveling R (1967) Die akute Erkrankung. Universitäts-Verlag, KölnGoogle Scholar
  302. Niederman JC, Miller G, Pearson HA, Pagano JS, Dowaliby JM (1976) Infectious mononucleosis: EBvirus shedding in saliva and the oropharynx. N Engl J Med 294: 1355–1359PubMedCrossRefGoogle Scholar
  303. Nilsson K (1979) The nature of lymphoid cell lines and their relationship to the virus. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 225–281CrossRefGoogle Scholar
  304. Nilsson K, Klein G, Henle W, Henle G (1971) The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer 8: 443–450PubMedGoogle Scholar
  305. Nonoyama M, Pagaono JS (1971) Homology between Epstein-Barr virus DNA and viral DNA from Burkitt’s lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature 242: 44–47CrossRefGoogle Scholar
  306. Old L, Boyse EA. Oettgen HF, Harven E de, Geering G, Williamson S, Clifford P (1966) Precipitating antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proc Natl Acad Sci USA 56: 1699–1704PubMedCrossRefGoogle Scholar
  307. O’Conor GT (1970) Persistent immunologic stimulation as a factor in oncogenesis with special reference to Burkitt’s tumor. Am J Red 48: 279–285Google Scholar
  308. Otte HJ, Brandis H (1978) Lehrbuch der medizinischen Mikrobiologie. G Fischer, Stuttgart New YorkGoogle Scholar
  309. Papermichail M, Sheldon PJ, Holoborow EG (1974) T & B cell populations in infectious mononucleosis. Clin Exp Immunol 18: 1–6Google Scholar
  310. Papp K (1956) Experiences prouvant que la voie d’infection de la rougeole est la contamination de le muqueuse conjonctivale. Revve Immunol Ther Anti-Microb 20: 27–36Google Scholar
  311. Paradise JL (1980) Viral otitis media. J Pediatrics 65: 917–924Google Scholar
  312. Pardue ML, Gall JG (1969) Molecular hybridization of radioactive DNA to the DNA of cytological preparations. Proc Natl Acad Sci USA 64: 600–604PubMedCrossRefGoogle Scholar
  313. Parrott RH, Ross S, Burke FG (1951) Herpangina. Clinical studies of a specific infectious disease. N Engl J Med 245: 275–280PubMedCrossRefGoogle Scholar
  314. Parving A, Vejtorp M, Miller K, Miller JK (1981) Congenital hearing loss and rubella infection. Acta Otolaryngol (Stockh) 90: 262–266CrossRefGoogle Scholar
  315. Pattengale PK, Smith RW, Gerber P (1973) Selective transformation of B-lymphocytes by EB virus. Lancet 2: 93–94PubMedCrossRefGoogle Scholar
  316. Pattengale PK, Smith RW, Gerber P (1974) B-cell characteristics of human peripheral and cord blood lymphocytes transformed by Epstein-Barr virus. J Nat Cancer Inst 52: 1081–1086PubMedGoogle Scholar
  317. Pattengale PK, Smith RW, Perlin E (1974) Atypical lymphocytes in acute infectious mononucleosis. N Engl J Med 291: 1145–1148PubMedCrossRefGoogle Scholar
  318. Payne FE, Baublis JV, Itabashi HH (1969) Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis. N Engl J Med 281: 585–589PubMedCrossRefGoogle Scholar
  319. Pauling LC (1974) Are recommended daily allowances for vitamin C adequate? Proc Natl Acad Sci USA 71: 4442–4446PubMedCrossRefGoogle Scholar
  320. Pauling LC (1970) Vitamin C and the common cold. WH Freeman, San FranciscoGoogle Scholar
  321. Pearson GR, Johansson B, Klein G (1978) Antibody-dependent cellular cytotoxicity against cells expressing Epstein-Barr virus antigens. J Nat Cancer Inst 22: 120–125Google Scholar
  322. Pereira MS and MacCallum FO (1964) Infection with adenovirus type 12. Lancet 1: 198–199PubMedCrossRefGoogle Scholar
  323. Pereira MS (1973) Adenovirus infections. Postgrad Med 49: 799–801Google Scholar
  324. Pereira MS, Field AM, Blake JM, Rodgers FG, Bailey LA, Davies JR (1972) Evidence for oral excretion of EB virus in infectious mononucleosis. Lancet 1: 710–711PubMedCrossRefGoogle Scholar
  325. Philip RN, Reinhard KR, Lackman DB (1959) Observations on a mumps epidemic in a “virgin” population. Am J Hyg 69: 91–111PubMedGoogle Scholar
  326. Pineda RG, Desmond MM, Rudolph AJ (1968) Impact of the 1964 rubella epidemic on a clinic population. Am J Obstet Gynecol 100: 1139–1146PubMedGoogle Scholar
  327. Pope JH (1967) Establishment of cell lines from leucocytes in peripheral mononucleosis. Nature (Lond) 216: 810–811CrossRefGoogle Scholar
  328. Pope JH, Horne MK, Scott W (1968) Transformation of fetal human leucocytes in vitro by filtrates of a human leucemie cell line containing herpes-like virus. Int J Cancer 3: 857–866PubMedCrossRefGoogle Scholar
  329. Pope JH, Scott W, Moss DJ (1973) Human lymphoid cell transformation by Epstein-Barr virus. Nature 246: 140–141Google Scholar
  330. Pulvertaft RJV (1964) Cytology of Burkitt’s tumor (African lymphome). Lancet 1: 238–241PubMedCrossRefGoogle Scholar
  331. Purtilo DT (1980) Immunopathogenesis and complications of infectious mononucleosis. Pathol Ann 15: 253–299Google Scholar
  332. Purtilo DT (1980) Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections. In: Sommers SC, Rosen PP (eds) Pathologoy Annual. Appleton Century Crofts, New York, pp 253–299Google Scholar
  333. Purtilo DT, Sakamoto K (1982) Epstein-Barr virus and human disease: Immune responses determine the clinical and pathologic expression. Engl Hum Pathol 12: 677–679CrossRefGoogle Scholar
  334. Purtilo DT (1981) The X-linked lymphoproliferative syndrome as a model. Advances in Cancer Research 34: 279–312 for EBV-induced oncogenesisPubMedCrossRefGoogle Scholar
  335. Rapp F (1974) Herpes viruses and cancer. Adv Cancer Res 19: 265–281PubMedCrossRefGoogle Scholar
  336. Rasmussen LE, Jordan GW, Stevens A (1974) Lymphocyte interferon production and transformation after herpes simplex infection in humans. J Immunol 112: 728–736PubMedGoogle Scholar
  337. Rawls WE, Tomkins WAF, Melnick JL (1969) The association of herpesvirus type 2 and carcinoma of the cervix. Am J Epidemiol 89: 547–554PubMedGoogle Scholar
  338. Reedman BM, Klein G (1973) Cellular localization of an Epstein-Barr virus associated complement fixing antigen in producer and nonproducer lymphoblastoid cell lines. Int J Cancer 11: 599–620CrossRefGoogle Scholar
  339. Richards CS (1964) Middle ear changes in rubella deafness. Arch Otolaryng 80: 48–59PubMedCrossRefGoogle Scholar
  340. Rickinson AB, Wallace LE, Epstein-MA (1980) HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells. Nature 283: 865–867PubMedCrossRefGoogle Scholar
  341. Rocchi G, Arangio-Ruiz G, Giannini V (1970) Detection of viraemia in acute respiratory disease of man. Acta Virol 14: 405–407PubMedGoogle Scholar
  342. Roizman B (1972) The biological features of herpes virus-infected cells, particularly as they relate to their possible oncogenicity. A review. In: Bigg PM, Thé G de, Payne LN (eds) Oncogenesis and herpesviruses. IARC, Lyon, pp 1–17Google Scholar
  343. Rossen RD, Kasel JA, Couch RB (1971) The secretory immune system: Its relation to respiratory viral infection. Progr Med Virol 13: 194–238Google Scholar
  344. Rotkin ID (1973) A comparison review of key epidemiological studies in cervical cancer related to recurrent searches for transmissible agents. Cancer Res 33: 1353–1367PubMedGoogle Scholar
  345. Rowe WP, Huebner RJ, Gilmore LK (1953) Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 84: 570–573PubMedGoogle Scholar
  346. Rowe WP, Harley JW, Cramblet HG (1958) Detection of human salivary gland virus in the mouth and urine of children. Am J Hyg 67: 57–62PubMedGoogle Scholar
  347. Rozee KR, Lee SHS (1977) Interferon action: nonviral alterations of cells. In: Stewart NE II (ed) Interferons and their actions. CRC Press Inc, Cleveland, pp 133–154Google Scholar
  348. Sakamoto K, Freed H, Purtilo DT (1980) Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome. J Immunol 125: 921–933PubMedGoogle Scholar
  349. Salaman MH, Wedderburn N, Bruce-Chwatt LJ (1969) The immune suppression effect of a murine plasmodium and its interaction with murine oncogenic viruses. J Gen Microbiol 59: 383–391PubMedGoogle Scholar
  350. Sando I, Wood R II (1971) Congenital middle ear anormalies. Otolaryng Clin N Amer 4: 291–295Google Scholar
  351. Seifert G (1959) Die Speicheldrüsen-Viruskrankheit Cytomegalie. Med Klin 59: 1734–1741Google Scholar
  352. Seifert G (1961) Die morphologische Diagnose der Cytomegalie. Münchn Med Wschr 103: 103–139Google Scholar
  353. Seifert G, Oekone Z (1957) Pathologie und Klinik der Cytomegalie. VEB Thieme, LeipzigGoogle Scholar
  354. Seigneurin JM, Vuillaume M, Lenoir G, The G de (1977) Replication of EB virus: Ultrastructural and immunofluorescent studies of P3HR1 superinfected Raji cells. J Virol 24: 836–845PubMedGoogle Scholar
  355. Sesterhenn K, Krueger GRF, Bertram G, Sesterhenn I (1982) Zum lymphoepithelialen Karzinom des Oropharynx. HNO 30: 243–249PubMedGoogle Scholar
  356. Shambaugh G, Hagens E, Holdermann J (1928) Statistical studies of children in public schools for the deaf. Arch Otolaryng 7: 424–513Google Scholar
  357. Shanmugaratnam K (1971) Studies on the etiology of nasopharyngeal carcinoma. Int Rev Path 10: 361–413Google Scholar
  358. Shope T, Dechario D, Miller G (1973) Malignant lymphoma in cotton-top marmosets following inoculation of Epstein-Barr virus. Proc Nati Acad Sci USA 70: 2487–2491CrossRefGoogle Scholar
  359. Siegel M, Fuerst HT, Peress NF (1966) Comparative fetal mortality in maternal virus diseases, a prospective study on rubella, measles, mumps, chickenpox, and hepatitis. N Engl J Med 274: 768–771PubMedCrossRefGoogle Scholar
  360. Siegel M (1973) Congenital malformations following chickenpox, measles, mumps, and hepatitis. JAMA 226: 1521–1524PubMedCrossRefGoogle Scholar
  361. Sikora K (1981) Does interferon cure cancer? Brit Med J 281: 855–858CrossRefGoogle Scholar
  362. Simons MJ, Wee GB, Day NE, Thé G de. Morris PJ, Shanmugaratnam K (1974) Immunogenetic aspects of nasopharyngeal carcinoma. I. Differences in HL-A antigen profiles between patients and comparison groups. Int J Cancer 13: 122–134PubMedCrossRefGoogle Scholar
  363. Simmons FB (1968) Theory of membrane breaks in sudden hearing loss. Arch Otolaryng 88: 67–74Google Scholar
  364. Smith CB, Purcell RH, Chanock RM (1967) Effect of amantadine hydrochloride on parainfluenza type 1 virus infections in adult volunteers. Am REv Resp Dis 95: 689–690PubMedGoogle Scholar
  365. Smith JM (1956) Complications of infectious mononucleosis. Ann Intern Med 44: 861–873PubMedGoogle Scholar
  366. Smith GA, Gussen R (1976) Inner ear pathologic features following mumps infection. Arch Otolaryng 102: 108–111PubMedCrossRefGoogle Scholar
  367. Söltz-Szöts J (1965) Klinische Bemerkungen zur Klinik and Therapie des Herpes zoster. Z Haut-u Geschl-Kr 38: 123–132Google Scholar
  368. Söltz-Szöts J (1971) Neue Methoden be der Behandlung der Viruserkrankungen der Haut. Z Hautkr 46: 755–760Google Scholar
  369. Söltz-Szöts J (1976) Therapie der Viruserkrankungen der Haut. Hautarzt (Suppl) 1: 11–16Google Scholar
  370. Spencer MJ, Cherry JD (1981) Adenoviral infections. In: Feigin, Cherry (eds) Textbook of pediatric infectious diseases. Saunders, Philadelphia, pp 1279–1291Google Scholar
  371. Spiess H (1981) Der pränatale and perinatale Virusinfekt. Mediz Verlagsgesellschaft mbH, Marburg/LahnGoogle Scholar
  372. Spiessmann EG (1936) Vasomotor responses of the mucosa of the upper respiratory tract to thermal stimuli. Amer J Physiol 115: 181–187Google Scholar
  373. Spoendlin H, Kistler G (1978) Papovavirus in human laryngeal papillomas. Arch Otorhinolaryngol 218: 289–292PubMedCrossRefGoogle Scholar
  374. Spoendlin H (1979) Anatomisch pathologische Aspekte der Elektrostimulation des erkrankten Innenohrs. ARch Oto-Rhino-Laryng 223: 1–50CrossRefGoogle Scholar
  375. Sullivan JL, Byron K, Brewster F, Purtilo DT (1980) Deficient natural killer cell activity in the X-linked lymphoproliferative syndrome. Science 210: 543–545PubMedCrossRefGoogle Scholar
  376. Sundmacher R, Neumann-Haffelin D, Cantell K (1976) Interferon treatment of dentritric keratitis. Lancet 1: 1406–1407PubMedCrossRefGoogle Scholar
  377. Sundmacher R, Cantell K, Neumann-Haffelin D (1978) Combination therapy of dentritic keratitis of the trifluorothymidine and interferon. Lancet 2: 687–688PubMedCrossRefGoogle Scholar
  378. Schall L, Lurie M, Kelemen G (1951) Embryonic hearing organs after maternal rubella. Laryngoscope 61: 99-ffPubMedCrossRefGoogle Scholar
  379. Scheibe A (1892) A case of deaf-mutism with auditory atrophy and anomalies of development in the membranous labyrinth of both ears. Arch Otolaryg 11: 12-ffGoogle Scholar
  380. Schmidt WAK, Brade L, Munteferting H (1978) Course of Coxsackie B antibodies during juvenile diabetes. Med Microbiol Immunol 164: 291–298PubMedCrossRefGoogle Scholar
  381. Schiff GM, Sutherland JM, Light IJ (1965) Studies on congenital rubella. Preliminary results on the frequency and significance of presence of rubella virus in the newborn and the effect of y-globulin in preventing congenital rubella. Am J Dis Child 110: 441–443PubMedGoogle Scholar
  382. Schmincke A (1921) Über lymphoepitheliale Geschwülste. Beitr Pathol 68: 161–170Google Scholar
  383. Schneweis KE (1962) Der cytopathische Effekt des HSV. Stammdifferenzen, Stabilität, Einfluß von Immunseren und Beziehungen zur Pockengröße. Zbl Bakt 1 Orig 186: 467–494Google Scholar
  384. Schouten TJ, Weimar W, Bos CE, Bos JH, Cremers CWRJ, Schellekens H (1982) Treatment of juvenile laryngeal papillomatosis with two types of interferon. Laryngoscope 92: 686–688PubMedCrossRefGoogle Scholar
  385. Schryver A de, Friberg S, Klein G, Henle W, Henle G, Thé G de, Clifford P, Ho HC (1969) Epstein-Barr virus-associated antibody patterns in carcinoma of the postnasal space. Clin Exp Immunol 5: 443–459PubMedGoogle Scholar
  386. Schryver A de, Klein G, Henle G, Henle W, Cameron H, Santesson L, Clifford P (1972) EB virus associated serology in malignant disease: Antibody levels to viral capsid antigens (VCA), membrane antigens (MA), and early antigens ( EA) in patients with various neoplastic conditions. Int J Cancer 9: 353–364PubMedCrossRefGoogle Scholar
  387. Schryver A de, Klein G, Henle W, Henle G (1974) EB virus-associated antibodies in Caucasian patients with carcinoma of the nasopharynx and in long-term suvivors after treatments. Int J Cancer 13: 319–325PubMedCrossRefGoogle Scholar
  388. Schulte-Holthausen (1975) Persistence of herpes virus DNA. 3rd International Congress of Virology, MadridGoogle Scholar
  389. Schulte-Holthausen H, Schneweis KE (1975) Differentiation of HSV, serotypes 1 and 2by DNA-DNA hybridization. Med Microbiol Immunol 161: 279–285PubMedCrossRefGoogle Scholar
  390. Schuknecht HF, Benitez J, Beekhuis J, Igarashi M, Singleton G, Rüedli L (1962) The pathology of sudden deafness. Laryngoscope 72: 1142–1157PubMedCrossRefGoogle Scholar
  391. Schwartz AR, Togo Y, Hornick RB (1973) Evaluation of the efficacy of ascorbic acid in prophylaxis of induced rhinovirus 44 infection in man. J Infect Dis 128: 500–505PubMedCrossRefGoogle Scholar
  392. Stange G, Neveling R (1980) Hörsturz. In: Berendes J, Link R, Zöllner F (eds) HNO-Heilkunde in Praxis und Klinik, Bd 6, Chr II, G Thieme, Stuttgart New York, pp 45–45. 31Google Scholar
  393. Stanley ED, Jackson GG, Panusarn C (1975) Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA 231: 1248–1251PubMedCrossRefGoogle Scholar
  394. Sterner G (1962) Adenovirus infection in childhood. An epidemiological and clinical survey among Swedish children. Acta Paediatr 142: 5–30Google Scholar
  395. Strander H, Cantell K (1974) Studies on antiviral and antitumor effects of human leukocyte interferon in vitro and in vivo. In: Waymouth C (ed) The production and use of interferon for the treatment and prevention of human virus infections. Tissue Culture Association, Rockville, pp 46–59Google Scholar
  396. Strander H (1977) Interferons: Antineoplastic drugs. Blut 35: 277–288PubMedCrossRefGoogle Scholar
  397. Strander H, Einhorn S (1977) Effect of human leukocytes interferon on the growth of human osteosarcoma cells in tissue culture. Int J Cancer 19: 468–473PubMedCrossRefGoogle Scholar
  398. Strauss M, Davis GL (1973) Viral disease of the labyrinth: I. Review of the literature and discussion of the role of cytomegalievirus in congenital deafness. Ann Oto-Rhino-Laryngol 82: 577–583Google Scholar
  399. Taylor L, Parsons-Smith G (1969) Infectious mononucleosis, deafness and facial paralysis. J Laryngol Otol 83: 613–616PubMedCrossRefGoogle Scholar
  400. Terrahe K (1972) Diagnostik der Mißbildungen des Ohres und des Ohrschädels. Arch Ohr- Nas-und Kehlk-Heilk 202: 85–151CrossRefGoogle Scholar
  401. Thé G de, Geser A, Day NE, Tukei PM, Williams EH, Beni DP, Smith PG, Dean AG, Bornkamm GW, Feorino P, Henle W (1978) Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma: Results of the prospective study. Nature 274: 756–761CrossRefGoogle Scholar
  402. Thorley-Lawson DA, Chess L, Strominger JL (1977) Suppression of in vitro Epstein-Barr virus antigens: A new role for adult T-lymphocytes. J Expt Med 146: 495–508CrossRefGoogle Scholar
  403. Tiedemann R (1979) Seröse und seromuköse Entzündungen des Mittelohres. In: Berendes J, Link R, Zöllner F (eds) HNO-Heilkunde in Praxis und Klinik. G Thieme, Stuttgart New York, pp 24–24.30Google Scholar
  404. Tilles JG, Klein JO, Jao RL (1967) Acute otitis media in children. N Engl J Med 277: 613–618PubMedCrossRefGoogle Scholar
  405. Tremonti LP, Lin JS, Jackson GG (1968) Neutralizing activity in nasal secretions and serum in resistance of volunteers to parainfluenza virus type 2. J Immunol 101: 572–577PubMedGoogle Scholar
  406. Treuner J, Niethammer D, Dannecker G, Hagmann R, Neef V, Hofschneider PH (1980) Successful treatment of nasopharyngeal carcinoma with interferon. Lancet 1: 817–818PubMedCrossRefGoogle Scholar
  407. Treuner J, Niethammer D, Dannecker G, Jobke A, Aldenhoff P, Kremms B, Nessler G, Bömer H (1981) Treatment of nasopharyngeal carcinoma in children with fibroblast interferon. In: Grundmann (ed) Nasopharyngeal carcinoma, Cancer Campaign, Vol 5. G Fischer, Stuttgart New York, pp 309–316Google Scholar
  408. Trinchieri G, Saatoli D, Knowles BB (1977) Tumor cell lines induce interferon in human lymphocytes. Nature 270: 611–613PubMedCrossRefGoogle Scholar
  409. Trumper PA, Epstein MA, Giovanella BC (1976) Activation in vitro by BUDR of a production EB virus infection in the epithelial cells of nasopharyngeal carcinoma. Int J Cancer 17: 578–587PubMedCrossRefGoogle Scholar
  410. Tyrrell DAJ (1981) Interferon research may be taking off. Arch Dis Child 56: 163–164PubMedCrossRefGoogle Scholar
  411. Tyrrell DAJ, Bynoe ML (1965) Cultivation of a novel type of common cold virus in organ cultures. Br med J 1: 1467–1470PubMedCrossRefGoogle Scholar
  412. Tyrrell DAJ, Almeida JD (1967) Direct electron microscopy of organ culture for detection and characterization of viruses. Arch Virusforsch 22: 417–425PubMedCrossRefGoogle Scholar
  413. Tyrrell DAJ, Almeida JD, Berry DM (1968) Coronaviruses. Nature 220: 650–657CrossRefGoogle Scholar
  414. Ullmann EV (1923) On the etiology of the laryngeal papilloma. Acta Oto-Laryngol 5: 317–334Google Scholar
  415. Utz JP (1964) Clinical and laboratory studies of mumps. IV. Viremia and abnormal renal function. N Engl J Med 270: 1283–1286PubMedCrossRefGoogle Scholar
  416. Utz JP, Kasel JA, Cramblett HG (1957) Clinical and laboratory studies of mumps. I. Laboratory diagnosis by tissue culture techniques. N Engl J Med 257: 497–502PubMedCrossRefGoogle Scholar
  417. Van der Veen J, van der Ploeg G (1958) An outbreak of pharyngoconjunctival fever caused by types 3 and 4 adenovirus at Waalwijk, the Netherlands. Am J Hyg 68: 95–105Google Scholar
  418. Vernon M (1967) Meningitis and deafness: The problem, its physical, audiological, and educational manifestations in deaf children. Laryngoscope 77: 1856–1874PubMedCrossRefGoogle Scholar
  419. Vernon M (1969) Multiply handicapped deaf children: Medical, educational and psychological considerations. CEC Research Monograph, 18 (1)Google Scholar
  420. Vuori M, Lahikaine EA, Peltonen T (1962) Perceptive deafness in connection with mumps. Acta OtoLaryng (Stockh) 55: 231-CrossRefGoogle Scholar
  421. Waldmann RH, Ganguly R (1978) Effect of CP-20,961, an interferon inducer on upper respiratory tract infections due to rhonovirus type 21 in volunteers. J Infect Dis 138: 531–535CrossRefGoogle Scholar
  422. Walker GH, Bynoe ML, Tyrrell DAJ (1967) Trial of ascorbic acid in prevention of colds. Br Med J 1: 603–606PubMedCrossRefGoogle Scholar
  423. Wang CC, Little JB, Schulz MD (1962) Cancer of the nasopharynx: Its clinical and radiotherapeutic considerations. Cancer 15: 921–926PubMedCrossRefGoogle Scholar
  424. Ward PH, Lindsay RJ, Warner NE (1965) Cytomegalie inclusions disease affecting the temporal bone. Laryngoscope 75: 628–638PubMedGoogle Scholar
  425. Weller Th, Craig JM (1949) The isolation of mumps virus at autopsy. Am J Pathol 25: 1105–1106PubMedGoogle Scholar
  426. Wiesmann E (1978) Medizinische Mikrobiologie. G Thieme Stuttgart, 281Google Scholar
  427. Wigand R (1979) Virusdiagnostik bei Atemwegsinfektionen mit Ausnahme von Influenza. In: Spiess H (ed) Virusdiagnostik für Klinik und Praxis. Tagungsbericht der Deutschen Vereinigung zur Bekämpfung der Viruskrankheiten e. V. in Verbindung mit dem Deutschen Grünen Kreuz. München, pp 199–206Google Scholar
  428. Wilton JMA, Jvanyi L, Lehner T (1972) Cell-mediated immunity in herpesvirus hominis infections. Brit Med J 1: 723–726PubMedCrossRefGoogle Scholar
  429. Wilmes E, Roggendorf M (1979) Zur Virusätiologie des Hörsturzes. Z Laryng Rhinol 58: 817–820Google Scholar
  430. Wilmes E, Wolf H, Deinhardt F, Naumann HH (1979) Die Bedeutung von Epstein-Barr Virus-Antikörpern für Diagnose und Verlauf des Nasopharynxkarzinoms. Laryng Rhinol Otol 58: 911–915Google Scholar
  431. Wilmes E (1981) Untersuchung bei Primär-und Sekundärerkrankungen durch EB-Virus. Habilitationschrift.Google Scholar
  432. Wilmes E, Wolf H, Deinhardt F, Naumann HH (1981) EBV-serology in NPC and related malignancies. In: Grundmann E et al (eds) Nasopharyngeal carcinoma, Cancer Campaign, Vol 5. G Fischer Stuttgart, pp 145–150Google Scholar
  433. Wilmes E, Wolf H (1981) Der Nachweis von Epstein-Barr Virusgenomen in der Ohrspeicheldrüse (Untersuchungen zur Persistenz und Replikation von EBV in gesunden Personen). Laryng-Rhinol 60: 7–11CrossRefGoogle Scholar
  434. Wilmes E, Wolf H (1982) Zur viralen Gense von Karzinomen des Waldeyerschen Rachenringes (On the viral etiology of carcinomas in Waldeyer’s ring). Arch Otorhinolaryngology, Verh Bericht der Dt Ges für Hals-, Nasen-und Ohren-Heilkunde, Kopf-Hals-Chirurgie, Springer, Berlin Heidelberg New York, im DruckGoogle Scholar
  435. Wilmes E, Wolf H, Haus M. EBV und Tonsillenkarzinome (in Vorbereitung)Google Scholar
  436. Winter S (1969) Notes on mumps meningoencephalitis. Some features in 199 cases in children. Clin Pediatr. 8: 373–374CrossRefGoogle Scholar
  437. Wolf H, zur Hausen H, Becker V (1973) EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature 244: 245–247Google Scholar
  438. Wolf H, Werner J, zur Hausen H (1975) EBV DNA in nonlymphoid cells of nasopharyngeal carcinomas and in malignant lymphoma obtained after inoculation of EBV into cotton-top marmosets. Cold Spring Harbor Symp Quant Biol XXXIX: 791Google Scholar
  439. Wolf H, zur Hausen H, Klein G, Becker V, Henle G, Henle W (1975) Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in nonlymphoid nasopharyngeal carcinoma cells. Med Microbiol Immunol 161: 15–21PubMedCrossRefGoogle Scholar
  440. Wolf H, (1979) Präsenz und Expression von Herpesvirus-DNA im lytischen Zyklus und in Tumorzellen. Habilitationsschrift. Medizinische Fakultät der Ludwig-Maximilians-Universität MünchenGoogle Scholar
  441. Wolf H (1981) Die Verwendung verschiedener Nukleinsäurehybridisierungstechniken am Beispiel von EBV-korrelierten Erkrankungen. Verh Dtsch Ges Path 65: 47–57Google Scholar
  442. Wolf H, Wilmes E (1980) Evidence for the presence of EB viruses in the parotid gland. Cold Spring Harbor Symp Quant Biol XX XIXGoogle Scholar
  443. Wolf H, Wilmes E, Bayliss GJ (1981) Epstein-Barr virus: Its site of persistence and its role in the development of carcinomas. In: Neth R (ed) Modern trends in human leukemia IV. Haematology and Blood Transfusion Vol 26. Springer, Berlin Heidelberg, pp 191–196CrossRefGoogle Scholar
  444. Wolf H, Bayliss GJ, Wilmes E (1981) Biological properties of Epstein-Barr virus. In: Grundmann E et al (eds) Nasopharyngeal carcinoma, Cancer Campaign, Vol 5. G Fischer, Stuttgart New York, ppGoogle Scholar
  445. Wyler R (1977) Interferon und Herpes. Z Hautkr 52: 533–536PubMedGoogle Scholar
  446. Yabrov AA (1980) Interferon and nonspecific resistence. Human Sciences Press, New YorkGoogle Scholar
  447. Yata J, Desgranges C, Tachibana T, Thé G de, (1973) Separation of human lymphocytes forming spontaneous rosettes with sheep erythrocytes. Biomedicine 196: 475–477Google Scholar
  448. Younger JS, Stinebring WR, Taube SE (1965) Influence of inhibitors of protein synthesis on interferon formation in mice. Virology 27: 541–550CrossRefGoogle Scholar
  449. Zahorsky J (1920) Herpetic sore throat. South Med J 13: 871–872CrossRefGoogle Scholar
  450. Zajtschuk J, Matz G, Lindsay J (1972) Temporal bone pathology in herpes oticus. Ann Otol Rhinol Laryng 81: 331–334Google Scholar
  451. Zinserling A (1972) Peculiarities of lesion in viral and mycoplasma infections of the ‘respiratory tract. Virchows Arch Pathol Anat 356: 259–273CrossRefGoogle Scholar
  452. Zischka-Konorsa W, Jellinger K, Hohenegger M (1965) Zur Pathogenese von Herpesvirus-Erkrankungen mit besonderer Berücksichtigung der nekrotisierenden Herpes simplex-Encephalitis. Acta Neuropath 5: 252–274PubMedCrossRefGoogle Scholar
  453. Zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Santesson L, Clifford P (1970) EBVDNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature 228: 1056–1058PubMedCrossRefGoogle Scholar
  454. Zur Hausen H, Schulte-Holthausen H (1970) Presence of EB virus nucleic acid homology in a “virus-free” line of Burkitt tumor cells. Nature 227: 245–248PubMedCrossRefGoogle Scholar
  455. Zur Hausen H (1975) Oncogenic herpesviruses. Biochem Biophys Acta 417: 25–53PubMedGoogle Scholar
  456. Zur Hausen H, Schulte-Holthausen H. Wolf H, Dörries K, Egger H (1974) Attempts to detect virus-specific DNA in human tumor. II. Nucleic acid hybridization with complementary RNA of human herpes group viruses. Int J Cancer 13: 657–664PubMedCrossRefGoogle Scholar
  457. Zur Hausen H (1976) DNA viruses in human cancer. Biochemical approaches. Cancer Res 36: 414–416Google Scholar
  458. Zur Hausen H, Meinhof W, Schreiber W, Bornkamm GW (1974) Attempts to detect virus-specific DNA sequences in human tumors. I. Nucleic acid hybridization with complementary RNA of human wart virus. Int J Cancer 13: 650–656PubMedCrossRefGoogle Scholar
  459. Zur Hausen H, Gissmann L, Steiner W, Dippold W, Dreger J (1975) Human papilloma viruses and cancer. Bibl Haematol 43: 569–571PubMedGoogle Scholar
  460. Zur Hausen H (1980) The role of viruses in human tumors. Advances in Cancer Research 33: 77–107PubMedCrossRefGoogle Scholar

Übersichtsliteratur

  1. Debre R, Celers J (1970) Clinical virology. Saunders, New YorkGoogle Scholar
  2. Fenner F (1976) Classification and nomenclature of viruses. Intervirology 7: 1–115PubMedCrossRefGoogle Scholar
  3. Fenner F, White DO (1976) Medical virology. Academic Press, New York LondonGoogle Scholar
  4. Haas R, Vivell O (1965) Virus-und Rickettsieninfektion des Menschen. JF Lehmann, MünchenGoogle Scholar
  5. Jawetz E, Melnick JL, Adelberg EA (1980) Review of Medical Microbioloy. Lange Medical Publ, Los AngelesGoogle Scholar
  6. Klein P, Falke D (1977) Virologie (Medizinische Mikrobiologie I ). Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  7. Nasemann Th (1974) Viruskrankheiten der Haut, der Schleimhäute und des Genitales. G Thieme, StuttgartGoogle Scholar

EBV

  1. Epstein MA, Achong BG (1979) The Epstein-Barr virus. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar

Interferon

  1. Berg K, Heron I (1980) Production, purification and properties of human interferons. In: Springfello DA (ed) Interferon and interferon inducers. Marcel Dekker Inc, New YorkGoogle Scholar
  2. Cantell K. Hirvonen S, Mogensen KE, Pyhala L (1974) Human leukocyte interferon: production, purification, stability and animal experiments. In vitro 35: 37–38Google Scholar
  3. Goedell DV, Yelverton E, Ullrich A (1980) Human leukocyte interferon produced by E. coli is biologically active. Nature 6: 287–411Google Scholar
  4. Grossberg SE (1972) The interferons and their inducers: molecular and therapeutic considerations. N Engl J Med 287: 9–13CrossRefGoogle Scholar
  5. Gutterman JU, Blumenschein GR, Alexanian R (1980) Leukocyte interferon induced tumor regression in human metastatic breast cancer, multiple myeloma and malignant lymphoma. Ann Intern Med 93: 399–406PubMedGoogle Scholar
  6. Isaacs A, Lindenmann J (1957) Viral interference: I. The interferon. Proc R Soc Lond (Biol) 147: 258–267CrossRefGoogle Scholar
  7. Lever WF, Schaumberg-Lever G (1975) Histopathology of the skin. LippincottGoogle Scholar
  8. Padovan I, Brodarec I, Ikic D, Kenzevic M. Soos E (1981) Effect of interferon in therapy of skin and head and neck tumors. J Cancer Res Clin Oncol 100: 295–310PubMedCrossRefGoogle Scholar
  9. Stewart WE (1981) Interferon-System. Springer, Heidelberg Berlin New YorkGoogle Scholar
  10. Strander H (1977) Anti-tumor effects of interferon and its possible use as an anti-neoplastic agent in man. Tex Rep Biol Med 35: 429–435PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • E. Wilmes
    • 1
  • F. Deinhardt
    • 2
  1. 1.Klinik und Poliklinik für HNO-KrankeUniversität MünchenMünchen 70Bundesrepublik Deutschland
  2. 2.Max von Pettenkofer-Institut für Hygiene und Medizinische MikrobiologieUniversität MünchenMünchen 2Bundesrepublik Deutschland

Personalised recommendations